Hospitalization costs associated with leiomyoma

Citation
Sz. Zhao et al., Hospitalization costs associated with leiomyoma, CLIN THER, 21(3), 1999, pp. 563-575
Citations number
8
Categorie Soggetti
Pharmacology
Journal title
CLINICAL THERAPEUTICS
ISSN journal
01492918 → ACNP
Volume
21
Issue
3
Year of publication
1999
Pages
563 - 575
Database
ISI
SICI code
0149-2918(199903)21:3<563:HCAWL>2.0.ZU;2-Z
Abstract
The objective of this study was to determine the prevalence and cost of lei omyoma-related hospitalizations based on the Nationwide Inpatient Sample (N IS) of the Healthcare Cost and Utilization Project (HCUP-3). Data for 1991 and 1992 were obtained from the HCUP-NIS database, which includes an approx imate 20% sample of US hospital discharges. ICD-9 (International Classifica tion of Diseases, Ninth Revision) codes 218.0-218.2 and 218.9 were used to identify women between the ages of 15 and 64 years with the diagnosis of le iomyoma. The distribution of leiomyoma was described using demographic char acteristics, admission type, length of stay (LOS), mean total charge, speci fic leiomyoma diagnosis, principal procedure, and other diagnosed diseases. Among hospital admissions of women between the ages of 15 and 64 years dur ing 1991 and 1992, 26 to 28 admissions per 1000 included a diagnosis of lei omyoma. The highest rates of leiomyoma diagnosis were seen in women aged >4 0 years (65% and 70% for 1991 and 1992, respectively) and black women (26% and 27%, respectively). Approximately 90% of hospitalizations for leiomyoma were routine admissions, with the most common specific diagnosis being int ramural leiomyoma of the uterus. In 1992, patients with leiomyoma as the fi rst diagnosis (vs other diagnoses) had significantly lower mean LOS (3.1 vs 4.4 days; P < 0.001) and mean total charge ($5919 vs $6810; P < 0.001). To tal abdominal hysterectomy was performed on three quarters of the women ad mitted for leiomyoma, and these patients had longer mean LOS and higher tot al charges than those undergoing other procedures. Although not as costly a s other conditions, this common disorder among women of reproductive years requires expensive treatment and is a major burden on the health care syste m.